- Home
- REKR vs ADAP Comparison
REKR vs ADAP Comparison
Compare REKR & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- ADAP
- Stock Information
- Founded
- REKR 2017
- ADAP 2008
- Country
- REKR United States
- ADAP United Kingdom
- Employees
- REKR N/A
- ADAP N/A
- Industry
- REKR Telecommunications Equipment
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- ADAP Health Care
- Exchange
- REKR Nasdaq
- ADAP Nasdaq
- Market Cap
- REKR 144.4M
- ADAP 158.6M
- IPO Year
- REKR N/A
- ADAP 2015
- Fundamental
- Price
- REKR $1.60
- ADAP $0.58
- Analyst Decision
- REKR Buy
- ADAP Strong Buy
- Analyst Count
- REKR 1
- ADAP 4
- Target Price
- REKR N/A
- ADAP $2.79
- AVG Volume (30 Days)
- REKR 12.0M
- ADAP 2.3M
- Earning Date
- REKR 11-14-2024
- ADAP 03-05-2025
- Dividend Yield
- REKR N/A
- ADAP N/A
- EPS Growth
- REKR N/A
- ADAP N/A
- EPS
- REKR N/A
- ADAP N/A
- Revenue
- REKR $43,817,000.00
- ADAP $175,041,000.00
- Revenue This Year
- REKR $33.40
- ADAP $204.91
- Revenue Next Year
- REKR $41.09
- ADAP N/A
- P/E Ratio
- REKR N/A
- ADAP N/A
- Revenue Growth
- REKR 44.46
- ADAP 146.27
- 52 Week Low
- REKR $0.78
- ADAP $0.53
- 52 Week High
- REKR $3.78
- ADAP $2.05
- Technical
- Relative Strength Index (RSI)
- REKR 54.50
- ADAP 41.87
- Support Level
- REKR $1.40
- ADAP $0.55
- Resistance Level
- REKR $1.72
- ADAP $0.65
- Average True Range (ATR)
- REKR 0.36
- ADAP 0.05
- MACD
- REKR -0.03
- ADAP 0.00
- Stochastic Oscillator
- REKR 36.66
- ADAP 31.31
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.